Page 87 - Lipids News Today

Whether or not someone develops Parkinson's disease may be a game of nanometers.

Greenwood Genetic Center researchers are reporting the discovery of a mechanism that contributes to the tissue phenotypes seen in PMM2-CDG, the most common of the congenital disorders of glycosylation (CDGs).

In a large-scale study of people from diverse ancestries, researchers narrowed down the number of genomic variants that are strongly associated with blood lipid levels and generated a polygenic risk score to predict elevated low-density lipoprotein cholesterol levels, a major risk factor for heart disease.

An elevated resting heart rate may be an independent risk factor for dementia and accelerated cognitive decline in older adults.

The FDA continues to advise close monitoring of patients treated with paclitaxel-coated balloons and stents for PAD while investigation into potential safety concerns continues.

To improve cholesterol management in diabetes, clinician-patient discussions are crucial, addressing risk/benefits and treatment goals, and offering reputable sources of information.

A new study suggests that post-exercise premature ventricular contractions might flag individuals at long-term risk for cardiovascular death.

Göran Walldius and colleagues investigate the long-term risk of a major cardiovascular event by apoB, apoA-1 and apoB/apoA-1 ratio in the Swedish AMORIS cohort.

Cardiovascular diseases (CVDs) are the leading cause of death globally. Monitoring of lipid in patients with coronary heart disease (CHD) is important for decreasing the incidence of cardiovascular events.

A non-physician-led program has the potential to expand remote healthcare delivery, increase access to care, reduce health inequities, and improve healthcare quality, researchers report.